Deleterious heteroplasmic mitochondrial mutations are associated with an increased risk of overall and cancer-specific mortality.
Hong YS, Battle SL, Shi W, Puiu D, Pillalamarri V, Xie J, Pankratz N, Lake NJ, Lek M, Rotter JI, Rich SS, Kooperberg C, Reiner AP, Auer PL, Heard-Costa N, Liu C, Lai M, Murabito JM, Levy D, Grove ML, Alonso A, Gibbs R, Dugan-Perez S, Gondek LP, Guallar E, Arking DE.
Hong YS, et al. Among authors: gondek lp.
Nat Commun. 2023 Sep 30;14(1):6113. doi: 10.1038/s41467-023-41785-7.
Nat Commun. 2023.
PMID: 37777527
Free PMC article.